domperidone has been researched along with cannabidiol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Seeman, P | 1 |
1 other study(ies) available for domperidone and cannabidiol
Article | Year |
---|---|
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose.
Topics: Animals; Antipsychotic Agents; Binding, Competitive; Brain; Cannabidiol; Domperidone; Dose-Response Relationship, Drug; Humans; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology | 2016 |